Proposal for standardized prenatal assessment of fetal open dysraphisms by the European reference network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies (ITHACA) and eUROGEN.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
19 Jun 2024
Historique:
revised: 14 05 2024
received: 24 01 2024
accepted: 29 05 2024
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 20 6 2024
Statut: aheadofprint

Résumé

Open dysraphisms, that is, myelomeningocele and myeloschisis, are rare diseases associated with a risk of severe disability, including lower limb motor and sensory deficiency, sphincter deficiency, and potential intellectual deficiency. Open dysraphism is diagnosed in Europe in 93.5% of cases. In case of suspicion of fetal open dysraphism, a detailed fetal morphologic assessment is required to confirm the diagnosis and exclude associated structural anomalies, as well as genetic assessment. In case of isolated fetal open dysraphism, assessment of prognosis is based on fetal imaging including the level of the lesion, the presence or not of a sac, the presence and nature of intra cranial anomalies, and the anatomical and functional evaluation of the lower extremities. Based on these biomarkers, a personalized prognosis as well as comprehensive information about prenatal management alternatives will allow parents to decide on further management options. Standardization of prenatal assessment is essential to compare outcomes with benchmark data and make assessment of surgical innovation possible. Herein, we propose a protocol for the standardized ultrasound assessment of fetuses with isolated open dysraphism.

Identifiants

pubmed: 38898590
doi: 10.1002/pd.6618
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Spin@ Reference Center, Paris, France

Informations de copyright

© 2024 John Wiley & Sons Ltd.

Références

Regulation (EC) 141/2000 of the European parliament and of the council of 16 December 1999 on orphan medicinal products.
European Commission website [internet]. Accessed January 24, 2024. https://ec.europa.eu/health/non‐communicable‐diseases/steering‐group/rare‐diseases_en
ERN ITHACA website [Internet].Accessed January 24, 2024. https://ern‐ithaca.eu/about‐us/what‐we‐do/
Tortori‐Donati P, Rossi A, Cama A. Spinal dysraphism: a review of neuroradiological features with embryological correlations and proposal for a new classification. Neuroradiology. 2000;42(7):471‐491. https://doi.org/10.1007/s002340000325
Ben‐Sira L, Garel C, Malinger G, Constantini S. Prenatal diagnosis of spinal dysraphism. Childs Nerv Syst. 2013;29(9):1541‐1552. https://doi.org/10.1007/s00381‐013‐2178‐5
EUROCAT prevalence chart and tables [Internet]. Accessed January 24, 2024. https://eu‐rd‐platform.jrc.ec.europa.eu/eurocat/eurocat‐data/prenatal‐screening‐and‐diagnosis_en
Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001(3):CD001056.
Lumley J, Watson L, Watson M, Bower C. Withdrawn: periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2011;2011(4):CD001056. https://doi.org/10.1002/14651858.cd001056.pub2
de la Fournière B, Dhombres F, Maurice P, et al. Prevention of neural tube defects by folic acid supplementation: a national population‐based study. Nutrients. 2020;12(10):3170. https://doi.org/10.3390/nu12103170
Kancherla V, Botto LD, Rowe LA, et al. Preventing birth defects, saving lives, and promoting health equity: an urgent call to action for universal mandatory food fortification with folic acid. Lancet Glob Health. 2022;10(7):e1053‐e1057. https://doi.org/10.1016/s2214‐109x(22)00213‐3
Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. Spina bifida. Lancet. 2004;364(9448):1885‐1895. https://doi.org/10.1016/s0140‐6736(04)17445‐x
Yang J, Cummings EA, O'connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006;108(3 Pt 1):644‐650. https://doi.org/10.1097/01.aog.0000231688.08263.47
Mowla S, Gissler M, Räisänen S, Kancherla V. Association between maternal pregestational diabetes mellitus and spina bifida: a population‐based case‐control study, Finland, 2000‐2014. Birth Defects Res. 2020;112(2):186‐195. https://doi.org/10.1002/bdr2.1624
Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics. 2003;111(5 Pt 2):1152‐1158. https://doi.org/10.1542/peds.111.s1.1152
Groenen PM, van Rooij IA, Peer PG, Gooskens RH, Zielhuis GA, Steegers‐Theunissen RP. Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. Am J Obstet Gynecol. 2004;191(1):11‐17. https://doi.org/10.1016/j.ajog.2003.12.032
Matalon S, Schechtman S, Goldzweig G, Ornoy A. The teratogenic effect of carbamazepine: a meta‐analysis of 1255 exposures. Reprod Toxicol. 2002;16(1):9‐17. https://doi.org/10.1016/s0890‐6238(01)00199‐x
Hernández‐Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343(22):1608‐1614. https://doi.org/10.1056/nejm200011303432204
Agopian AJ, Tinker SC, Lupo PJ, Canfield MA, Mitchell, LE. National Birth Defects Prevention Study. Proportion of neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol. 2013;97(1):42‐46. https://doi.org/10.1002/bdra.23100
Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA. Spina bifida outcome: a 25‐year prospective. Pediatr Neurosurg. 2001;34(3):114‐120. https://doi.org/10.1159/000056005
Spaggiari E, Dreux S, Stirnemann JJ, et al. Impact on spina bifida screening of shifting prenatal down syndrome maternal serum screening from the second trimester to the first. Prenat Diagn. 2017;37(7):673‐679. https://doi.org/10.1002/pd.5064
Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364(11):993‐1004. https://doi.org/10.1056/nejmoa1014379
Houtrow AJ, Thom EA, Fletcher JM, et al. Prenatal repair of myelomeningocele and school‐age functional outcomes. Pediatrics. 2020;145(2):e20191544. https://doi.org/10.1542/peds.2019‐1544
Johnson MP, Bennett KA, Rand L, et al. The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. Am J Obstet Gynecol. 2016;215(6):778.e1‐778.e9. 778.e1‐778.e9. https://doi.org/10.1016/j.ajog.2016.07.052
Russo FM, Cordier AG, De Catte L, Saada J, Benachi A, Deprest J. Proposal for standardized prenatal ultrasound assessment of the fetus with congenital diaphragmatic hernia by the European reference network on rare inherited and congenital anomalies (ERNICA). Prenat Diagn. 2018;38(9):629‐637. https://doi.org/10.1002/pd.5297
Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH. Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11‐13 weeks. Prenat Diagn. 2011;31(1):90‐102. https://doi.org/10.1002/pd.2642
Ovaere C, Eggink A, Richter J, et al. Prenatal diagnosis and patient preferences in patients with neural tube defects around the advent of fetal surgery in Belgium and Holland. Fetal Diagn Ther. 2015;37(3):226‐234. https://doi.org/10.1159/000365214
Engels AC, Joyeux L, Brantner C, et al. Sonographic detection of central nervous system defects in the first trimester of pregnancy. Prenat Diagn. 2016;36(3):266‐273. https://doi.org/10.1002/pd.4770
Timor‐Tritsch IE, Bashiri A, Monteagudo A, Arslan AA. Qualified and trained sonographers in the US can perform early fetal anatomy scans between 11 and 14 weeks. Am J Obstet Gynecol. 2004;191(4):1247‐1252. https://doi.org/10.1016/j.ajog.2004.03.007
Chaoui R, Benoit B, Mitkowska‐Wozniak H, Heling KS, Nicolaides KH. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11‐13‐week scan. Ultrasound Obstet Gynecol. 2009;34(3):249‐252. https://doi.org/10.1002/uog.7329
Scheier M, Lachmann R, Pětroš M, Nicolaides KH. Three‐dimensional sonography of the posterior fossa in fetuses with open spina bifida at 11‐13 weeks' gestation. Ultrasound Obstet Gynecol. 2011;38(6):625‐629. https://doi.org/10.1002/uog.9067
Mangione R, Dhombres F, Lelong N, et al. Screening for fetal spina bifida at the 11‐13‐week scan using three anatomical features of the posterior brain. Ultrasound Obstet Gynecol. 2013;42(4):416‐420. https://doi.org/10.1002/uog.12463
Finn M, Sutton D, Atkinson S, et al. The aqueduct of Sylvius: a sonographic landmark for neural tube defects in the first trimester. Ultrasound Obstet Gynecol. 2011;38(6):640‐645. https://doi.org/10.1002/uog.10088
Bernard JP, Cuckle HS, Bernard MA, Brochet C, Salomon LJ, Ville Y. Combined screening for open spina bifida at 11‐13 weeks using fetal biparietal diameter and maternal serum markers. Am J Obstet Gynecol. 2013;209(3):223.e1‐223.e5. 223.e1‐223.e2235. https://doi.org/10.1016/j.ajog.2013.05.024
Simon EG, Arthuis CJ, Haddad G, Bertrand P, Perrotin F. Biparietal/transverse abdominal diameter ratio ≤ 1: potential marker for open spina bifida at 11‐13‐week scan. Ultrasound Obstet Gynecol. 2015;45(3):267‐272. https://doi.org/10.1002/uog.13406
Meller C, Aiello H, Otaño L. Sonographic detection of open spina bifida in the first trimester: review of the literature. Childs Nerv Syst. 2017;33(7):1101‐1106. https://doi.org/10.1007/s00381‐017‐3443‐9
Special report, EUROCAT. Prenatal screening policies in Europe. [Internet]. 2010. Accessed January 24, 2024. https://www.orpha.net/actor/Orphanews/2010/doc/Special‐Report‐Prenatal‐Screening‐Policies.pdf
Malinger G, Paladini D, Haratz KK, Monteagudo A, Pilu GL, Timor‐Tritsch IE. ISUOG Practice Guidelines (updated): sonographic examination of the fetal central nervous system. Part 1: performance of screening examination and indications for targeted neurosonography [published correction appears in Ultrasound Obstet Gynecol. 2022 Oct;60(4):591]. Ultrasound Obstet Gynecol. 2020;56(3):476‐484. https://doi.org/10.1002/uog.22145
Nicolaides KH, Campbell S, Gabbe SG, Guidetti R. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet. 1986;2(8498):72‐74. https://doi.org/10.1016/s0140‐6736(86)91610‐7
Juranek J, Salman MS. Anomalous development of brain structure and function in spina bifida myelomeningocele. Dev Disabil Res Rev. 2010;16(1):23‐30. https://doi.org/10.1002/ddrr.88
Maurice P, Garel J, Garel C, et al. New insights in cerebral findings associated with fetal myelomeningocele: a retrospective cohort study in a single tertiary centre. BJOG. 2021;128(2):376‐383. https://doi.org/10.1111/1471‐0528.16185
Campbell J, Gilbert WM, Nicolaides KH, et al. Ultrasound screening for spina bifida: cranial and cerebellar signs in a high‐risk population. Obstet Gynecol. 1987;70(2):247‐250.
Cuppen I, de Bruijn D, Geerdink N, et al. Small biparietal diameter and head circumference are part of the phenotype instead of independent prognostic markers in fetuses with spinal dysraphism. Fetal Diagn Ther. 2015;37(2):135‐140. https://doi.org/10.1159/000366157
Coleman BG, Langer JE, Horii SC. The diagnostic features of spina bifida: the role of ultrasound. Fetal Diagn Ther. 2015;37(3):179‐196. https://doi.org/10.1159/000364806
Garel C, Alberti C. Coronal measurement of the fetal lateral ventricles: comparison between ultrasonography and magnetic resonance imaging. Ultrasound Obstet Gynecol. 2006;27(1):23‐27. https://doi.org/10.1002/uog.2666
Babcook CJ, Goldstein RB, Barth RA, Damato NM, Callen PW, Filly RA. Prevalence of ventriculomegaly in association with myelomeningocele: correlation with gestational age and severity of posterior fossa deformity. Radiology. 1994;190(3):703‐707. https://doi.org/10.1148/radiology.190.3.8115615
Fujisawa H, Kitawaki J, Iwasa K, Honjo H. New ultrasonographic criteria for the prenatal diagnosis of Chiari type 2 malformation. Acta Obstet Gynecol Scand. 2006;85(12):1426‐1429. https://doi.org/10.1080/00016340600645602
Callen AL, Filly RA. Supratentorial abnormalities in the Chiari II malformation, I: the ventricular "point. J Ultrasound Med. 2008;27(1):33‐38. https://doi.org/10.7863/jum.2008.27.1.33
Kunpalin Y, Deprest J, Papastefanou I, et al. Incidence and patterns of abnormal corpus callosum in fetuses with isolated spina bifida aperta. Prenat Diagn. 2021;41(8):957‐964. https://doi.org/10.1002/pd.5945
Benacerraf BR, Shipp TD, Bromley B, Levine D. What does magnetic resonance imaging add to the prenatal sonographic diagnosis of ventriculomegaly? J Ultrasound Med. 2007;26(11):1513‐1522. https://doi.org/10.7863/jum.2007.26.11.1513
Trigo L, Eixarch E, Bottura I, et al. Prevalence of supratentorial anomalies assessed by magnetic resonance imaging in fetuses with open spina bifida. Ultrasound Obstet Gynecol. 2022;59(6):804‐812. https://doi.org/10.1002/uog.23761
Wong SK, Barkovich AJ, Callen AL, Filly RA. Supratentorial abnormalities in the Chiari II malformation, III: the interhemispheric cyst. J Ultrasound Med. 2009;28(8):999‐1006. https://doi.org/10.7863/jum.2009.28.8.999
Didier RA, Martin‐Saavedra JS, Oliver ER, et al. Fetal intraventricular hemorrhage in open neural tube defects: prenatal imaging evaluation and perinatal outcomes. AJNR Am J Neuroradiol. 2020;41(10):1923‐1929. https://doi.org/10.3174/ajnr.a6745
Sawin KJ, Liu T, Ward E, et al. The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr. 2015;166(2):444‐450.e1. https://doi.org/10.1016/j.jpeds.2014.09.039
Oliver ER, Heuer GG, Thom EA, et al. Myelomeningocele sac associated with worse lower‐extremity neurological sequelae: evidence for prenatal neural stretch injury? Ultrasound Obstet Gynecol. 2020;55(6):740‐746. https://doi.org/10.1002/uog.21891
Mottet N, Saada J, Jani J, et al. Sonographic evaluation of fetal Conus medullaris and filum terminale. Fetal Diagn Ther. 2016;40(3):224‐230. https://doi.org/10.1159/000443731
Hershkovitz R. Prenatal diagnosis of isolated abnormal number of ribs. Ultrasound Obstet Gynecol. 2008;32(4):506‐509. https://doi.org/10.1002/uog.5296
Buyukkurt S, Binokay F, Seydaoglu G, et al. Prenatal determination of the upper lesion level of spina bifida with three‐dimensional ultrasound. Fetal Diagn Ther. 2013;33(1):36‐40. https://doi.org/10.1159/000341568
Requeijo MJ, Bunduki V, Francisco RP, Ruano R, Zugaib M. Comparison of two‐ and three‐dimensional ultrasonography in the evaluation of lesion level in fetuses with spina bifida. Rev Bras Ginecol Obstet. 2016;38(3):120‐126. https://doi.org/10.1055/s‐0036‐1580711
Di Mascio D, Greco F, Rizzo G, et al. Diagnostic accuracy of prenatal ultrasound in identifying the level of the lesion in fetuses with open spina bifida: a systematic review and meta‐analysis. Acta Obstet Gynecol Scand. 2021;100(2):210‐219. https://doi.org/10.1111/aogs.14001
Sherrod BA, Ho WS, Hedlund A, Kennedy A, Ostrander B, Bollo RJ. A comparison of the accuracy of fetal MRI and prenatal ultrasonography at predicting lesion level and perinatal motor outcome in patients with myelomeningocele. Neurosurg Focus. 2019;47(4):E4. https://doi.org/10.3171/2019.7.focus19450
Gunay H, Sozbilen MC, Gurbuz Y, Altinisik M, Buyukata B. Incidence and type of foot deformities in patients with spina bifida according to level of lesion. Childs Nerv Syst. 2016;32(2):315‐319. https://doi.org/10.1007/s00381‐015‐2944‐7
Brasseur‐Daudruy M, Abu Amara S, Ickowicz‐Onnient V, Touleimat S, Verspyck E. Clubfoot versus positional foot deformities on prenatal ultrasound imaging. J Ultrasound Med. 2020;39(3):615‐623. https://doi.org/10.1002/jum.15136
Mummareddy N, Dewan MC, Mercier MR, Naftel RP, Wellons JC, Bonfield CM. Scoliosis in myelomeningocele: epidemiology, management, and functional outcome. J Neurosurg Pediatr. 2017;20(1):99‐108. https://doi.org/10.3171/2017.2.peds16641
Mu W, He M, Lei T, Zhang L, Xie H. Measurement of the Cobb angle by 3D ultrasound: a valuable additional method for the prenatal evaluation of congenital scoliosis. Quant Imaging Med Surg. 2022;12(5):2805‐2812. https://doi.org/10.21037/qims‐21‐558
Cho FN, Kan YY, Yang TL, Huang HP, Hsu PH, Tai MH. Prenatal diagnosis of sharp‐angled lumbosacral kyphosis with myelomeningocele and spina bifida in a fetus. J Ultrasound Med. 2004;23(8):1115‐1119. https://doi.org/10.7863/jum.2004.23.8.1115
Pedreira DA, Zanon N, Nishikuni K, et al. Endoscopic surgery for the antenatal treatment of myelomeningocele: the CECAM trial. Am J Obstet Gynecol. 2016;214(1):111.e1‐111.e11. 111.e1‐111.e11. https://doi.org/10.1016/j.ajog.2015.09.065
Belfort MA, Whitehead WE, Shamshirsaz AA, et al. Fetoscopic open neural tube defect repair: development and refinement of a two‐port, carbon dioxide insufflation technique. Obstet Gynecol. 2017;129(4):734‐743. https://doi.org/10.1097/aog.0000000000001941
Möhrlen U, Ochsenbein‐Kölble N, Mazzone L, et al. Benchmarking against the MOMS trial: Zurich results of open fetal surgery for spina bifida. Fetal Diagn Ther. 2020;47(2):91‐97. https://doi.org/10.1159/000500049
Guilbaud L, Maurice P, Lallemant P, et al. Open fetal surgery for myelomeningocele repair in France. J Gynecol Obstet Hum Reprod. 2021;50(9):102155. https://doi.org/10.1016/j.jogoh.2021.102155
Tsitouras V, Sgouros S. Syringomyelia and tethered cord in children. Childs Nerv Syst. 2013;29(9):1625‐1634. https://doi.org/10.1007/s00381‐013‐2180‐y
Has R, Yuksel A, Buyukkurt S, Kalelioglu I, Tatli B. Prenatal diagnosis of diastematomyelia: presentation of eight cases and review of the literature. Ultrasound Obstet Gynecol. 2007;30(6):845‐849. https://doi.org/10.1002/uog.4066
Kumar R, Bansal KK, Chhabra DK. Occurrence of split cord malformation in meningomyelocele: complex spina bifida. Pediatr Neurosurg. 2002;36(3):119‐127. https://doi.org/10.1159/000048366
Lowry RB, Bedard T, MacFarlane AJ, Crawford S, Sibbald B, Agborsangaya BC. Prevalence rates of spina bifida in Alberta, Canada: 2001‐2015. Can we achieve more prevention? Birth Defects Res. 2019;111(3):151‐158. https://doi.org/10.1002/bdr2.1438
Dean JH, Pauly R, Stevenson RE. Neural tube defects and associated anomalies before and after folic acid fortification. J Pediatr. 2020;226:186‐194.e4. https://doi.org/10.1016/j.jpeds.2020.07.002
Butler KM, Fee T, DuPont BR, Dean JH, Stevenson RE, Lyons MJ. A SOX3 duplication and lumbosacral spina bifida in three generations. Am J Med Genet A. 2022;188(5):1572‐1577. https://doi.org/10.1002/ajmg.a.62668
Sival DA, Begeer JH, Staal‐Schreinemachers AL, Vos‐Niël J, Beekhuis J, Prechtl H. Perinatal motor behaviour and neurological outcome in spina bifida aperta. Early Hum Dev. 1997;50(1):27‐37. https://doi.org/10.1016/s0378‐3782(97)00090‐x
Carreras E, Maroto A, Illescas T, et al. Prenatal ultrasound evaluation of segmental level of neurological lesion in fetuses with myelomeningocele: development of a new technique. Ultrasound Obstet Gynecol. 2016;47(2):162‐167. https://doi.org/10.1002/uog.15732
Maroto A, Illescas T, Meléndez M, et al. Ultrasound functional evaluation of fetuses with myelomeningocele: study of the interpretation of results. J Matern Fetal Neonatal Med. 2017;30(19):2301‐2305. https://doi.org/10.1080/14767058.2016.1247262
Corroenne R, Yepez M, Pyarali M, et al. Longitudinal evaluation of motor function in patients who underwent prenatal or postnatal neural tube defect repair. Ultrasound Obstet Gynecol. 2021;58(2):221‐229. https://doi.org/10.1002/uog.22165
Maiz N, Arévalo S, García‐Manau P, et al. Presurgery motor level assessment for prediction of motor level at birth in fetuses undergoing prenatal repair of open spina bifida: time to abandon anatomical level in counseling. Ultrasound Obstet Gynecol. 2023;61(6):728‐733. https://doi.org/10.1002/uog.26180
Blondiaux E, Katorza E, Rosenblatt J, et al. Prenatal US evaluation of the spinal cord using high‐frequency linear transducers. Pediatr Radiol. 2011;41(3):374‐383. https://doi.org/10.1007/s00247‐010‐1922‐1
Saleem SN, Said AH, Abdel‐Raouf M, et al. Fetal MRI in the evaluation of fetuses referred for sonographically suspected neural tube defects (NTDs): impact on diagnosis and management decision. Neuroradiology. 2009;51(11):761‐772. https://doi.org/10.1007/s00234‐009‐0549‐0
Mufti N, Sacco A, Aertsen M, et al. What brain abnormalities can magnetic resonance imaging detect in foetal and early neonatal spina bifida: a systematic review. Neuroradiology. 2022;64(2):233‐245. https://doi.org/10.1007/s00234‐021‐02853‐1
Aertsen M, Verduyckt J, De Keyzer F, et al. Reliability of MR imaging‐based posterior fossa and brain stem measurements in open spinal dysraphism in the era of fetal surgery. AJNR Am J Neuroradiol. 2019;40(1):191‐198. https://doi.org/10.3174/ajnr.a5930
Mignone Philpott C, Shannon P, Chitayat D, Ryan G, Raybaud CA, Blaser SI. Diffusion‐weighted imaging of the cerebellum in the fetus with Chiari II malformation. AJNR Am J Neuroradiol. 2013;34(8):1656‐1660. https://doi.org/10.3174/ajnr.a3468
Shrot S, Soares BP, Whitehead MT. Cerebral diffusivity changes in fetuses with Chiari II malformation. Fetal Diagn Ther. 2019;45(4):268‐274. https://doi.org/10.1159/000490102
Sanz Cortes M, Corroenne R, Sangi‐Haghpeykar H, et al. Association between ambulatory skills and diffusion tensor imaging of corpus callosal white matter in infants with spina bifida. Ultrasound Obstet Gynecol. 2022;60(5):657‐665. https://doi.org/10.1002/uog.24958
Jakab A, Pogledic I, Schwartz E, et al. Fetal cerebral magnetic resonance imaging beyond morphology. Semin Ultrasound CT MR. 2015;36(6):465‐475. https://doi.org/10.1053/j.sult.2015.06.003
Harmon JP, Hiett AK, Palmer CG, et al. Prenatal ultrasound detection of isolated neural tube defects: is cytogenetic evaluation warranted? Obstet Gynecol. 1995;86(4 Pt 1):595‐599. https://doi.org/10.1016/0029‐7844(95)00206‐7
Chong HP, Hamilton S, Mone F, et al. Prenatal chromosomal microarray testing of fetuses with ultrasound structural anomalies: a prospective cohort study of over 1000 consecutive cases. Prenat Diagn. 2019;39(12):1064‐1069. https://doi.org/10.1002/pd.5545
Santirocco M, Plaja A, Rodó C, et al. Chromosomal microarray analysis in fetuses with central nervous system anomalies: an 8‐year long observational study from a tertiary care university hospital. Prenat Diagn. 2021;41(1):123‐135. https://doi.org/10.1002/pd.5829
Zemet R, Krispin E, Johnson RM, et al. Implication of chromosomal microarray analysis prior to in‐utero repair of fetal open neural tube defect. Ultrasound Obstet Gynecol. 2023;61(6):719‐727. https://doi.org/10.1002/uog.26152
Wolujewicz P, Aguiar‐Pulido V, AbdelAleem A, et al. Genome‐wide investigation identifies a rare copy‐number variant burden associated with human spina bifida. Genet Med. 2021;23(7):1211‐1218. https://doi.org/10.1038/s41436‐021‐01126‐9
Dulard E, Boue C, Muller F, et al. Electrophoresis of cholinesterases of the amniotic fluid in the prenatal diagnosis of closure defects of the neural tube. J Gynecol Obstet Biol Reprod (Paris). 1988;17(1):45‐50.
Friszer S, Dhombres F, Morel B, Zerah M, Jouannic JM, Garel C. Limited dorsal myeloschisis: a diagnostic pitfall in the prenatal ultrasound of fetal dysraphism. Fetal Diagn Ther. 2017;41(2):136‐144. https://doi.org/10.1159/000445995
Pang D, Zovickian J, Oviedo A, Moes GS. Limited dorsal myeloschisis: a distinctive clinicopathological entity. Neurosurgery. 2010;67(6):1555‐1580. https://doi.org/10.1227/neu.0b013e3181f93e5a
Pang D, Zovickian J, Wong ST, Hou YJ, Moes GS. Limited dorsal myeloschisis: a not‐so‐rare form of primary neurulation defect. Childs Nerv Syst. 2013;29(9):1459‐1484. https://doi.org/10.1007/s00381‐013‐2189‐2
Zerah M, de Saint Denis T, Garel C, Jouannic JM, Di Rocco F. An intermediate form of dysraphism: the MyeLDM. Childs Nerv Syst. 2020;36(7):1333‐1334. https://doi.org/10.1007/s00381‐020‐04631‐5
Vande Perre S, Guilbaud L, de Saint‐Denis T, et al. The myelic limited dorsal malformation: prenatal ultrasonographic characteristics of an intermediate form of dysraphism. Fetal Diagn Ther. 2021;48(9):690‐700. https://doi.org/10.1159/000519060
Gotha L, Pruthi V, Abbasi N, et al. Fetal spina bifida: what we tell the parents. Prenat Diagn. 2020;40(12):1499‐1507. https://doi.org/10.1002/pd.5802

Auteurs

Lucie Guilbaud (L)

Fetal Medicine Department, Armand Trousseau University Hospital, Spin@ Reference Center, Sorbonne University, Paris, France.

Elena Carreras (E)

Maternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Catherine Garel (C)

Pediatric Radiology Department, Armand Trousseau University Hospital, Sorbonne University, Paris, France.

Nerea Maiz (N)

Maternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Ferdinand Dhombres (F)

Fetal Medicine Department, Armand Trousseau University Hospital, Spin@ Reference Center, Sorbonne University, Paris, France.

Jan Deprest (J)

Clinical Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.
Institute of Women's Health, University College London, London, UK.

Jean-Marie Jouannic (JM)

Fetal Medicine Department, Armand Trousseau University Hospital, Spin@ Reference Center, Sorbonne University, Paris, France.

Classifications MeSH